Association of heart rate and left ventricular structure in a rural population in Korea

References

• Kannel WB, Gordon T, Offutt D. Left ventricular hypertrophy by electrocardiogram. Prevalence, incidence, and mortality in the Framingham study. Ann Intern Med 1969;71:89–105
   PubMed Web of Science ®Google Scholar
• Levy D, Garrison RJ, Savage DD, et al. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Eng J Med 1990;322:1561–6
   PubMed Web of Science ®Google Scholar
• Levy D, Anderson KM, Savage DD, et al. Echocardiographically detected left ventricular hypertrophy: prevalence and risk factors. The Framingham Heart Study. Ann Intern Med 1988;108:7–13
   PubMed Web of Science ®Google Scholar
• Gerdts E, Cramariuc D, de Simone G, et al. Impact of left ventricular geometry on prognosis in hypertensive patients with left ventricular hypertrophy (the LIFE study). Eur J Echocardiogr 2008;9:809–15
   PubMed Web of Science ®Google Scholar
• Drazner MH, Rame JE, Marino EK, et al. Increased left ventricular mass is a risk factor for the development of a depressed left ventricular ejection fraction within five years: the Cardiovascular Health Study. J Am Coll Cardiol 2004;43:2207–15
   PubMed Web of Science ®Google Scholar
• Devereux RB, Roman MJ, Paranicas M, et al. Impact of diabetes on cardiac structure and function: the strong heart study. Circulation 2000;101:2271–6
   PubMed Web of Science ®Google Scholar
• Devereux RB, Pickering TG, Alderman MH, et al. Left ventricular hypertrophy in hypertension. Prevalence and relationship to pathophysiologic variables. Hypertension 1987;9:1153–60
   Web of Science ®Google Scholar
• Yoo KY, Shin HR, Chang SH, et al. Genomic epidemiology cohorts in Korea: present and the future. Asian Pac J Cancer Prev 2005;6:238–43
   PubMedGoogle Scholar
• Rein P, Saely CH, Muendlein A, et al. Serial decline of kidney function as a novel biomarker for the progression of atherothrombotic disease. Atherosclerosis 2010;211:348–52
   PubMed Web of Science ®Google Scholar
• van der Velde M, Bakker SJ, de Jong PE, Gansevoort RT. Influence of age and measure of eGFR on the association between renal function and cardiovascular events. Clin J Am Soc Nephrol 2010;5:2053–9
   PubMed Web of Science ®Google Scholar
• Devereux RB, Dahlof B, Gerdts E, et al. Regression of hypertensive left ventricular hypertrophy by losartan compared with atenolol: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) trial. Circulation 2004;110:1456–62
   PubMed Web of Science ®Google Scholar
• Poulter NR, Dobson JE, Sever PS, et al. Baseline heart rate, antihypertensive treatment, and prevention of cardiovascular outcomes in ASCOT (Anglo-Scandinavian Cardiac Outcomes Trial). J Am Coll Cardiol 2009;54:1154–61
   PubMed Web of Science ®Google Scholar
• Yang YJ, Choi BY, Chun BY, et al. Dietary zinc intake is inversely related to subclinical atherosclerosis measured by carotid intima-media thickness. Br J Nutr 2010;104:1202–11
   PubMed Web of Science ®Google Scholar
• Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009;150:604–12
   PubMed Web of Science ®Google Scholar
• Devereux RB, Alonso DR, Lutas EM, et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986;57:450–8
   PubMed Web of Science ®Google Scholar
• Lieb W, Mayer B, Stritzke J, et al. Association of low-grade urinary albumin excretion with left ventricular hypertrophy in the general population: the MONICA/KORA Augsburg Echocardiographic Substudy. Nephrol Dial Transplant 2006;21:2780–7
   PubMed Web of Science ®Google Scholar
• Fox ER, Taylor J, Taylor H, et al. Left ventricular geometric patterns in the Jackson cohort of the Atherosclerotic Risk in Communities (ARIC) Study: clinical correlates and influences on systolic and diastolic dysfunction. Am Heart J 2007;153:238–44
   PubMed Web of Science ®Google Scholar
• Gosse P, Dallocchio M. Left ventricular hypertrophy: epidemiological prognosis and associated critical factors. Eur Heart J 1993;14:16–21
   PubMed Web of Science ®Google Scholar
• Saba MM, Ibrahim MM, Rizk HH. Gender and the relationship between resting heart rate and left ventricular geometry. J Hypertens 2001;19:367–73
   PubMed Web of Science ®Google Scholar
• O’Rourke MF, Safar ME. Letter regarding article by Devereux et al, “regression of hypertensive left ventricular hypertrophy by losartan compared with atenolol: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) trial”. Circulation 2005;111:e377 . doi:10.1161/CIRCULATIONAHA.104.525519
   PubMed Web of Science ®Google Scholar
• Aumann N, Baumeister SE, Werner A, et al. Inverse association of estimated cystatin C- and creatinine-based glomerular filtration rate with left ventricular mass: results from the Study of Health in Pomerania. Int J Cardiol 2012 Aug 8. [Epub ahead of print]. doi:10.1016/j.ijcard.2012.07.011
   PubMedGoogle Scholar
• Fesler P, Du Cailar G, Ribstein J, Mimran A. Left ventricular remodeling and renal function in never-treated essential hypertension. J Am Soc Nephrol 2003;14:881–7
   PubMed Web of Science ®Google Scholar
• Chagnac A, Herman M, Zingerman B, et al. Obesity-induced glomerular hyperfiltration: its involvement in the pathogenesis of tubular sodium reabsorption. Nephrol Dial Transplant 2008;23:3946–52
   PubMed Web of Science ®Google Scholar
• Henry RM, Kamp O, Kostense PJ, et al. Mild renal insufficiency is associated with increased left ventricular mass in men, but not in women: an arterial stiffness-related phenomenon – the Hoorn Study. Kidney Int 2005;68:673–9
   PubMed Web of Science ®Google Scholar
• Jesudason DR, Clifton P. Interpreting different measures of glomerular filtration rate in obesity and weight loss: pitfalls for the clinician. Int J Obes (Lond) 2012;36:1421–7
   PubMed Web of Science ®Google Scholar
• Wuerzner G, Bochud M, Giusti V, Burnier M. Measurement of glomerular filtration rate in obese patients: pitfalls and potential consequences on drug therapy. Obes Facts 2011;4:238–43
   PubMed Web of Science ®Google Scholar
• Jafary FH, Jafar TH. Disproportionately high risk of left ventricular hypertrophy in Indo-Asian women: a call for more studies. Echocardiography 2008;25:812–9
   PubMed Web of Science ®Google Scholar
• Zhan S, Liu M, Yao W, et al. Prevalence and relevant factors on echocardiographic left ventricular hypertrophy among community-based hypertensive patients in Shanghai. Zhonghua Liu Xing Bing Xue Za Zhi 2002;23:182–5
   PubMedGoogle Scholar
• Schirmer H, Lunde P, Rasmussen K. Prevalence of left ventricular hypertrophy in a general population; the Tromso Study. Eur Heart J 1999;20:429–38
   PubMed Web of Science ®Google Scholar
• Gardin JM, Siscovick D, Anton-Culver H, et al. Sex, age, and disease affect echocardiographic left ventricular mass and systolic function in the free-living elderly. The Cardiovascular Health Study. Circulation 1995;91:1739–48
   PubMed Web of Science ®Google Scholar
• Kardys I, Deckers JW, Stricker BH, et al. Distribution of echocardiographic parameters and their associations with cardiovascular risk factors in the Rotterdam Study. Eur J Epidemiol 2010;25:481–90
   PubMed Web of Science ®Google Scholar
• Rodrigues SL, Baldo MP, Sa Cunha R, et al. Anthropometric measures of increased central and overall adiposity in association with echocardiographic left ventricular hypertrophy. Hypertens Res 2010;33:83–7
   PubMed Web of Science ®Google Scholar
• Rodrigues SL, Angelo LC, Pereira AC, et al. Determinants of left ventricular mass and presence of metabolic risk factors in normotensive individuals. Int J Cardiol 2009;135:323–30
   PubMed Web of Science ®Google Scholar
• Alpert MA, Lambert CR, Terry BE, et al. Interrelationship of left ventricular mass, systolic function and diastolic filling in normotensive morbidly obese patients. Int J Obes Relat Metab Disord 1995;19:550–7
   PubMed Web of Science ®Google Scholar
• Savage DD, Levy D, Dannenberg AL, et al. Association of echocardiographic left ventricular mass with body size, blood pressure and physical activity (the Framingham Study). Am J Cardiol 1990;65:371–6
   PubMed Web of Science ®Google Scholar